Company
NTrans Technologies
- Biotech
- Location:
- Leiden, Netherlands
Description
NTrans Technologies develops a non-viral delivery platform for cell and gene therapies, providing modular delivery solutions for applications such as CAR-T and prime editing to therapeutic developers and research partners.
NTrans Technologies is located in the Netherlands ecosystem.
Related
CPTxCPTx develops in vivo CAR-T genetic medicines using an immune-silent ssDNA platform and non-viral lipid nanoparticle delivery to encode…
- CeraVxCeraVx develops ceramic CeraMaps microneedle patches for intradermal delivery of vaccines and medicines, using biocompatible, inert…
VRG TherapeuticsVRG Therapeutics designs therapeutic miniproteins using a proprietary platform that combines AI-driven protein engineering with wet-lab…
CutanosCutanos develops LC-TDS, a ligand-based delivery platform that uses langerin-specific glycomimetic ligands on lipid nanoparticles to…
Trained Therapeutix DiscoveryTrained Therapeutix Discovery develops nanobiologic therapeutics that regulate trained immunity for applications in cancer and organ…
OrexoOrexo develops powder-based drug delivery technologies and therapeutic formulations, including AmorphOX®, used to improve bioavailability…
TQ TherapeuticsTQ Therapeutics operates a CELLfinity platform that delivers in vivo cell and gene therapies using a proprietary EXiVO automated approach…
Cleara BiotechCleara Biotech develops peptide-based therapies that selectively eliminate p53-impaired cancer cells; products include lead development…
ToxysToxys provides in vitro toxicity screening assays and services, including ToxTracker and ReproTracker, for mechanistic genotoxicity and…